Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

REMIFENTANIL FOR INJECTION 2 MG

REMIFENTANIL (REMIFENTANIL HYDROCHLORIDE) : 2 MG · DIN 02344432 · TEVA CANADA LIMITED

Health Canada status: CANCELLED POST MARKET

What is REMIFENTANIL FOR INJECTION?

REMIFENTANIL FOR INJECTION 2 MG contains REMIFENTANIL (REMIFENTANIL HYDROCHLORIDE) : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02344432, held by TEVA CANADA LIMITED, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02344432
Brand nameREMIFENTANIL FOR INJECTION
Generic / active ingredientREMIFENTANIL (REMIFENTANIL HYDROCHLORIDE) : 2 MG
ManufacturerTEVA CANADA LIMITED
Strength2 MG
Dosage formPOWDER FOR SOLUTION
Route of administrationINTRAVENOUS
ScheduleNARCOTICS (CDSA I)
ATC codeN01AH06 REMIFENTANIL
AHFS class28:08.08
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date30-Jul-2021
Original market date2014-06-05 00:00:00

What can be used instead?

Other Canadian products sharing ATC code N01AH06 REMIFENTANIL. 2 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
REMIFENTANIL HYDROCHLORIDE FOR INJECTION1 MGPOWDER FOR SOLUTIONSTERIMAX INCMARKETEDDIN 02366460
REMIFENTANIL HYDROCHLORIDE FOR INJECTION2 MGPOWDER FOR SOLUTIONSTERIMAX INCMARKETEDDIN 02366479
REMIFENTANIL FOR INJECTION1 MGPOWDER FOR SOLUTIONSANDOZ CANADA INCORPORATEDCANCELLED PRE MARKETDIN 02393204
REMIFENTANIL FOR INJECTION1 MGPOWDER FOR SOLUTIONTEVA CANADA LIMITEDCANCELLED POST MARKETDIN 02344424
REMIFENTANIL FOR INJECTION2 MGPOWDER FOR SOLUTIONSANDOZ CANADA INCORPORATEDCANCELLED PRE MARKETDIN 02393212
REMIFENTANIL HYDROCHLORIDE FOR INJECTION5 MGPOWDER FOR SOLUTIONSTERIMAX INCAPPROVEDDIN 02366495
ULTIVA1 MGPOWDER FOR SOLUTIONABBVIE CORPORATIONCANCELLED POST MARKETDIN 02230409
ULTIVA2 MGPOWDER FOR SOLUTIONABBVIE CORPORATIONCANCELLED POST MARKETDIN 02230410
ULTIVA5 MGPOWDER FOR SOLUTIONABBVIE CORPORATIONCANCELLED POST MARKETDIN 02230411

Who else supplies REMIFENTANIL worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. REMIFENTANIL appears in 50 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02344432. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.